Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Why AstraZeneca Should Have Examined Its Compensation Data

  • Broadcast in Business
  • 0 comments
TheProactiveEmployer

TheProactiveEmployer

×  

Follow This Show

If you liked this show, you should follow TheProactiveEmployer.
h:107452
s:2036769
archived

Recently, the Department of Labor announced that AstraZeneca will pay $250K to settle allegations of gender discrimination. The settlement decree also requires AstraZeneca to conduct a statistical analysis of base pay of sales specialists.

The statistical analysis is the key takeaway - it's better to examine your data before problems occur, rather than after.

In this installment of The Proactive Employer, we'll be discussing the AstraZeneca settlement decree, why the company should have been examining its compensation data in the first place, and how to go about a statistical analysis of compensation. We'll also discuss five key points that can keep your proactive analyses confidential, protected, and privileged.

Comments

 comments